BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 12783699)

  • 21. Ischemia-induced K-ras mutations in human colorectal cancer cells: role of microenvironmental regulation of MSH2 expression.
    Shahrzad S; Quayle L; Stone C; Plumb C; Shirasawa S; Rak JW; Coomber BL
    Cancer Res; 2005 Sep; 65(18):8134-41. PubMed ID: 16166287
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of vascular endothelial growth factor, receptor KDR and p53 protein in transitional cell carcinoma of the bladder.
    Liu L; Zhu D; Gao R; Guo H
    Urol Int; 2008; 81(1):72-6. PubMed ID: 18645275
    [TBL] [Abstract][Full Text] [Related]  

  • 23. K-ras and p53 gene mutations in colorectal cancer in 57 Japanese patients.
    Onda M; Abe R; Tsuchiya A; Fukushima T; Ando Y; Yoshida T
    Fukushima J Med Sci; 1997 Jun; 43(1):29-39. PubMed ID: 9431782
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Correlation of intratumoral microvessel density and p53 protein overexpression in human colorectal adenocarcinoma.
    Vermeulen PB; Roland L; Mertens V; Van Marck E; De Bruijn EA; Van Oosterom AT; Dirix LY
    Microvasc Res; 1996 Mar; 51(2):164-74. PubMed ID: 8778572
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of angiogenesis, p-53 tissue protein expression and serum VEGF in patients with endometrial cancer.
    Mazurek A; Pierzyński P; Kuć P; Kopinski P; Terlikowski S; Niklińska W; Trojan J; Laudański T
    Neoplasma; 2004; 51(3):193-7. PubMed ID: 15254672
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Expression of p53 and vascular endothelial growth factor in esophageal squamous cell carcinoma and their clinical significance].
    Liu DB; Chen KN; Cao XZ; Wang T
    Ai Zheng; 2002 Sep; 21(9):989-93. PubMed ID: 12508548
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alterations of the K-ras and p53 genes and microsatellite instability in sporadic colorectal carcinomas.
    Hasegawa A; Fukushima T; Mashiko M; Nakano K; Suzuki S; Endo Y; Ohki S; Hatakeyama Y; Koyama Y; Inoue N; Takebayashi Y; Sekikawa K; Takenoshita S
    Anticancer Res; 2004; 24(3b):2047-52. PubMed ID: 15274399
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of microsatellite instability, K-ras gene mutation and p53 protein overexpression in intrahepatic cholangiocarcinoma.
    Isa T; Tomita S; Nakachi A; Miyazato H; Shimoji H; Kusano T; Muto Y; Furukawa M
    Hepatogastroenterology; 2002; 49(45):604-8. PubMed ID: 12063950
    [TBL] [Abstract][Full Text] [Related]  

  • 29. VEGF and bFGF expression and microvessel density of maxillary sinus squamous cell carcinoma in relation to p53 status, spontaneous apoptosis and prognosis.
    Bandoh N; Hayashi T; Takahara M; Kishibe K; Ogino T; Katayama A; Imada M; Nonaka S; Harabuchi Y
    Cancer Lett; 2004 May; 208(2):215-25. PubMed ID: 15142681
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activation of the K-ras oncogene in colorectal neoplasms is associated with decreased apoptosis.
    Ward RL; Todd AV; Santiago F; O'Connor T; Hawkins NJ
    Cancer; 1997 Mar; 79(6):1106-13. PubMed ID: 9070487
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic events in sporadic colorectal adenomas: K-ras and p53 heterozygous mutations are not sufficient for malignant progression.
    De Benedetti L; Varesco L; Pellegata NS; Losi L; Gismondi V; Casarino L; Sciallero S; Bonelli L; Biticchi R; Bafico A
    Anticancer Res; 1993; 13(3):667-70. PubMed ID: 8317895
    [TBL] [Abstract][Full Text] [Related]  

  • 32. K-ras gene mutations in normal colorectal tissues from K-ras mutation-positive colorectal cancer patients.
    Zhu D; Keohavong P; Finkelstein SD; Swalsky P; Bakker A; Weissfeld J; Srivastava S; Whiteside TL
    Cancer Res; 1997 Jun; 57(12):2485-92. PubMed ID: 9192830
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CD44 expression in colorectal adenomas is an early event occurring prior to K-ras and p53 gene mutation.
    Kim H; Yang XL; Rosada C; Hamilton SR; August JT
    Arch Biochem Biophys; 1994 May; 310(2):504-7. PubMed ID: 7513984
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Overexpression of VEGF is associated with positive p53 immunostaining in hepatocellular carcinoma (HCC) and adverse outcome of HCC patients.
    Tseng PL; Tai MH; Huang CC; Wang CC; Lin JW; Hung CH; Chen CH; Wang JH; Lu SN; Lee CM; Changchien CS; Hu TH
    J Surg Oncol; 2008 Oct; 98(5):349-57. PubMed ID: 18646041
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CSE1L modulates Ras-induced cancer cell invasion: correlation of K-Ras mutation and CSE1L expression in colorectal cancer progression.
    Jiang MC; Yeh CM; Tai CJ; Chen HC; Lin SH; Su TC; Shen SC; Lee WR; Liao CF; Li LT; Lee CH; Chen YC; Yeh KT; Chang CC
    Am J Surg; 2013 Sep; 206(3):418-27. PubMed ID: 23806821
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mutant ras oncogenes upregulate VEGF/VPF expression: implications for induction and inhibition of tumor angiogenesis.
    Rak J; Mitsuhashi Y; Bayko L; Filmus J; Shirasawa S; Sasazuki T; Kerbel RS
    Cancer Res; 1995 Oct; 55(20):4575-80. PubMed ID: 7553632
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tissue factor expression in non-small cell lung cancer: relationship with vascular endothelial growth factor expression, microvascular density, and K-ras mutation.
    Regina S; Rollin J; Bléchet C; Iochmann S; Reverdiau P; Gruel Y
    J Thorac Oncol; 2008 Jul; 3(7):689-97. PubMed ID: 18594312
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interleukin-8 in non-small cell lung carcinoma: relation with angiogenic pattern and p53 alterations.
    Boldrini L; Gisfredi S; Ursino S; Lucchi M; Mussi A; Basolo F; Pingitore R; Fontanini G
    Lung Cancer; 2005 Dec; 50(3):309-17. PubMed ID: 16125276
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Role of P53, nm23 proteins and vascular endothelial growth factor in angiogenesis and metastasis of laryngeal cancer].
    Cheng W; Li X; Quan C; Guo X
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 2000 Apr; 35(2):147-9. PubMed ID: 12768677
    [TBL] [Abstract][Full Text] [Related]  

  • 40. p53 and K-ras mutations in pancreatic juice samples from patients with chronic pancreatitis.
    Löhr M; Müller P; Mora J; Brinkmann B; Ostwald C; Farré A; Lluis F; Adam U; Stubbe J; Plath F; Nizze H; Hopt UT; Barten M; Capellá G; Liebe S
    Gastrointest Endosc; 2001 Jun; 53(7):734-43. PubMed ID: 11375580
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.